Literature DB >> 14714217

Vascular risk and genetics of sporadic late-onset Alzheimer's disease.

F Panza1, A D'Introno, A M Colacicco, A M Basile, C Capurso, P G Kehoe, A Capurso, V Solfrizzi.   

Abstract

In recent years, it is becoming apparent that genes may play an important role in the development of late-onset Alzheimer's disease (LOAD), and genetic studies could unravel new clues. Based on a growing vascular hypothesis for the pathogenesis of LOAD and other dementias, there is increasing interest for environmental and genetic vascular factors. Polymorphisms in different susceptibility genes already implicated in vascular disease risk are now also being suggested as possible genetic markers for increased risk of developing LOAD; however, many of these studies have shown conflicting results. Thus far, the apolipoprotein E (APOE) gene seems to be the only vascular susceptibility factor that is agreed to play a role in the multifactorial pathogenesis of AD although emerging genetic and biological evidence is now strengthening the case for additional inclusion of angiotensin I-converting enzyme 1 (ACE1) into this category. This review will focus on the current knowledge on genetic and nongenetic vascular factors likely to be involved in LOAD, with special emphasis placed on the APOE and ACE1 genes.

Entities:  

Mesh:

Year:  2003        PMID: 14714217     DOI: 10.1007/s00702-003-0071-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

Review 1.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

2.  A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.

Authors:  Steven G Potkin; Gus Alva; Ibrahim Gunay; Barbara Koumaras; Michael Chen; Dario Mirski
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

Review 4.  Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment.

Authors:  V Solfrizzi; C Capurso; A D'Introno; A M Colacicco; V Frisardi; A Santamato; M Ranieri; P Fiore; G Vendemiale; D Seripa; A Pilotto; A Capurso; F Panza
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

Review 5.  Vascular risk factors, alcohol intake, and cognitive decline.

Authors:  F Panza; C Capurso; A D'Introno; A M Colacicco; V Frisardi; A Santamato; M Ranieri; P Fiore; G Vendemiale; D Seripa; A Pilotto; A Capurso; V Solfrizzi
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

6.  Variation at APOE and STH loci and Alzheimer's disease.

Authors:  Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-zhu Yang; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2006-04-07       Impact factor: 3.759

Review 7.  Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis.

Authors:  Yong Liu; Qicong Chen; Xu Liu; Mengmeng Dou; Silu Li; Jiahui Zhou; Hong Liu; Yongfu Wu; Zunnan Huang
Journal:  Biomed Res Int       Date:  2016-08-15       Impact factor: 3.411

8.  Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice.

Authors:  Dasha Fuentes; Nidia Fernández; Yenela García; Teidy García; Ana Ruth Morales; Roberto Menéndez
Journal:  Behav Sci (Basel)       Date:  2018-03-03

Review 9.  Vascular risk factors, cognitive decline, and dementia.

Authors:  E Duron; Olivier Hanon
Journal:  Vasc Health Risk Manag       Date:  2008

10.  The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study.

Authors:  Xiaochen Huang; Shengqi Dong; Jie Zhen; Huiqiang Zhang; Tong Lin; Yuhong Zeng; Nicholas Van Halm-Lutterodt; Linhong Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.